We are live on ! Find out more
CELUW

Celularity Inc

Delisted

CELUW was delisted on the 17th of July, 2026.

16 hedge funds and large institutions have $10.8K invested in Celularity Inc in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 1416 (+2)

0.69% more ownership

Funds ownership: 16.44%17.13% (+0.69%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

51% less capital invested

Capital invested by funds: $22.1K → $10.8K (-$11.4K)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

CELUW Hedge Fund Activity: Q2 2026 in Review

16 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q2 2026, worth a combined $10.8K — down 51% from $22.1K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CELUW positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Lombard Odier Asset Management (Europe), opening a new position worth an estimated $569. The largest seller was Susquehanna International Group, cutting an estimated $203.

  • 16 institutional investors held Celularity Inc (CELUW) as of Q2 2026, up from 14 in Q1 2026.
  • Funds reported $10.8K of Celularity Inc stock for Q2 2026, down 51% quarter-over-quarter.
  • 2 funds opened new Celularity Inc positions in Q2 2026 and 0 closed out, a net change of +2 holders.
  • The largest Celularity Inc buyer in Q2 2026 was Lombard Odier Asset Management (Europe), an estimated $569 added.
  • The largest Celularity Inc seller in Q2 2026 was Susquehanna International Group, an estimated $203 sold.

Based on aggregated 13F filings for Q2 2026.